Xenetic Biosciences annual ebitda
2013
2014
2015
2020
2021
2022
Xenetic Biosciences's calculated EBITDA was −$6.7M for fiscal 2022.
View full Xenetic Biosciences company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | −$6.7M | −$971,143 | — |
| 2021 | 2021-12-31 | −$5.7M | $8.2M | — |
| 2020 | 2020-12-31 | −$13.9M | −$4.2M | — |
| 2015 | 2015-12-31 | −$9.8M | $3.1M | — |
| 2014 | 2014-12-31 | −$12.8M | −$4.3M | — |
| 2013 · Dec 31 | 2013-12-31 | −$8.6M | — | — |
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2021 | 2021-09-30 | −$1.4M | $866,548 | — |
| Q2 2021 | 2021-06-30 | −$1.1M | $42.1M | — |
| Q3 2020 | 2020-09-30 | −$10.5M | −$8.7M | — |
| Q2 2020 | 2020-06-30 | −$982,259 | $1.7M | — |
| Q3 2016 | 2016-09-30 | −$2.2M | $1.5M | — |
| Q2 2016 | 2016-06-30 | −$43.3M | −$41.8M | — |
| Q1 2016 | 2016-03-31 | −$1.8M | −$35,545 | — |
| Q4 2015 | 2015-12-31 | −$2.7M | $1.5M | — |
| Q3 2015 | 2015-09-30 | −$3.8M | −$708,162 | — |
| Q2 2015 | 2015-06-30 | −$1.5M | $1.1M | — |
| Q1 2015 | 2015-03-31 | −$1.8M | $1.1M | — |
| Q4 2014 | 2014-12-31 | −$4.2M | −$1.7M | — |
| Q3 2014 | 2014-09-30 | −$3.1M | — | — |
| Q2 2014 | 2014-06-30 | −$2.6M | — | — |
| Q1 2014 · Mar 31 | 2014-03-31 | −$2.9M | — | — |
| Q3 2013 · Sep 30 | 2013-09-30 | −$2.5M | — | — |
Over the last five reported fiscal years, Xenetic Biosciences's ebitda increased from −$8.6M to −$6.7M, a change of $1.8M. The latest reported quarter, Q3 2021, shows −$1.4M.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xenetic Biosciences filings at SEC.gov ↗